The U.S. Food and Drug Administration recently expanded approval of Addyi, a daily pill for low sex drive, to postmenopausal ...

The once-a-day treatment, which acts on brain chemicals that affect mood and appetite, had initially been OK’d for ...

The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for ...

The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...

While the expanded approval fulfills an unmet meet in postmenopausal women, its benefits are marginal in that population.

Viagra, the little blue pill, has been a household name for more than a generation. And now women's sexual health is finally ...

Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire ...

On Dec. 15, Sprout Pharmaceuticals received approval to use its pill, Addyi (flibanserin), to treat low sexual desire in ...

The FDA has expanded the approval of Addyi to include the treatment of hypoactive sexual desire disorder in women less than 65 years.

The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...

Sprout Pharmaceuticals says the little pink pill called Addyi -- the first drug to boost sexual desire in women -- will hit the shelves of American pharmacies Oct. 17. But women who are anxiously ...